I would think they would have to wait until deadline in case there are shares being rescinded. Which I doubt.
Yes and no. The company is selling treasury shares to support ongoing operations. The stock will not rise until they start delivering on their contractual obligations, get a healthy buy-in from China, get licensing going to generate substantially more revenue and last but not least, get FDA concurrence. This continued talk of doing a R/S is bunk.
Which class action woulkd that be? lol
Unlike Rootin Tootin WankerWootinFatPrat who spits on us.